Skip to main content
OpenTrials

Clinical trial condition

Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN

Explore clinical trials studying Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN trial results

Completed

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

NCT02369874

Conditions
Disease Attributes, Head and Neck Neoplasms, Neoplasms, +5 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Fullerton, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Redondo Beach, California, United States
View all 168 locations
View Trial Details

Related conditions